Moody National Bank Trust Division’s Immunogen Inc IMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-45,860
Closed -$176K 631
2023
Q1
$176K Buy
45,860
+9,851
+27% +$42K 0.02% 589
2022
Q4
$179K Buy
36,009
+22,396
+165% +$121K 0.02% 583
2022
Q3
$65K Buy
+13,613
New +$71.8K 0.01% 576

Other funds holding IMGN

Moody National Bank Trust Division's IMGN Position: Q2 2023 in Review

Moody National Bank Trust Division sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 45,860 shares — an estimated $176K sold.

Moody National Bank Trust Division first reported a position in IMGN in Q3 2022 and held it in 3 quarters. The position peaked at $179K in Q4 2022. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • Moody National Bank Trust Division reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • Moody National Bank Trust Division sold 45,860 Immunogen Inc shares in Q2 2023, an estimated $176K.
  • Moody National Bank Trust Division first reported a position in Immunogen Inc in Q3 2022 and held it in 3 quarters.
  • Moody National Bank Trust Division's Immunogen Inc position peaked at $179K in Q4 2022.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Moody National Bank Trust Division's 13F filing for Q2 2023, filed 7 Jul 2023.